Suppr超能文献

间充质干细胞的自然史,从血管壁到培养容器。

Natural history of mesenchymal stem cells, from vessel walls to culture vessels.

机构信息

MRC Center for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.

出版信息

Cell Mol Life Sci. 2014 Apr;71(8):1353-74. doi: 10.1007/s00018-013-1462-6. Epub 2013 Oct 25.

Abstract

Mesenchymal stem/stromal cells (MSCs) can regenerate tissues by direct differentiation or indirectly by stimulating angiogenesis, limiting inflammation, and recruiting tissue-specific progenitor cells. MSCs emerge and multiply in long-term cultures of total cells from the bone marrow or multiple other organs. Such a derivation in vitro is simple and convenient, hence popular, but has long precluded understanding of the native identity, tissue distribution, frequency, and natural role of MSCs, which have been defined and validated exclusively in terms of surface marker expression and developmental potential in culture into bone, cartilage, and fat. Such simple, widely accepted criteria uniformly typify MSCs, even though some differences in potential exist, depending on tissue sources. Combined immunohistochemistry, flow cytometry, and cell culture have allowed tracking the artifactual cultured mesenchymal stem/stromal cells back to perivascular anatomical regions. Presently, both pericytes enveloping microvessels and adventitial cells surrounding larger arteries and veins have been described as possible MSC forerunners. While such a vascular association would explain why MSCs have been isolated from virtually all tissues tested, the origin of the MSCs grown from umbilical cord blood remains unknown. In fact, most aspects of the biology of perivascular MSCs are still obscure, from the emergence of these cells in the embryo to the molecular control of their activity in adult tissues. Such dark areas have not compromised intents to use these cells in clinical settings though, in which purified perivascular cells already exhibit decisive advantages over conventional MSCs, including purity, thorough characterization and, principally, total independence from in vitro culture. A growing body of experimental data is currently paving the way to the medical usage of autologous sorted perivascular cells for indications in which MSCs have been previously contemplated or actually used, such as bone regeneration and cardiovascular tissue repair.

摘要

间充质干细胞(MSCs)可以通过直接分化或间接通过刺激血管生成、限制炎症和募集组织特异性祖细胞来再生组织。MSCs 从骨髓或其他多种器官的总细胞的长期培养中出现并增殖。这种体外衍生方法简单方便,因此很受欢迎,但长期以来一直阻碍了对 MSCs 的固有特性、组织分布、频率和自然作用的理解,这些特性和作用仅根据表面标志物表达和在培养中向骨、软骨和脂肪的发育潜力来定义和验证。尽管存在一些潜在差异,取决于组织来源,但这种简单且被广泛接受的标准统一了 MSCs 的特性。结合免疫组织化学、流式细胞术和细胞培养,已经能够追踪人工培养的间充质干细胞/基质细胞回到血管周围的解剖区域。目前,已经描述了包裹微血管的周细胞和环绕较大动脉和静脉的外膜细胞作为 MSC 前体的可能来源。虽然这种血管关联可以解释为什么 MSCs 几乎可以从所有经过测试的组织中分离出来,但从脐带血中生长的 MSC 的来源仍然未知。事实上,从胚胎中这些细胞的出现到其在成人组织中活性的分子控制,周细胞 MSC 的生物学的大多数方面仍然不清楚。尽管如此,这些黑暗领域并没有影响将这些细胞用于临床环境的意图,其中纯化的周细胞已经表现出相对于传统 MSCs 的决定性优势,包括纯度、彻底的特征描述,以及主要是完全独立于体外培养。目前,越来越多的实验数据正在为自体分选的周细胞在已经考虑或实际使用 MSCs 的适应症中的医学用途铺平道路,例如骨再生和心血管组织修复。

相似文献

10

引用本文的文献

2
Towards Extracellular Vesicles in the Treatment of Epidermolysis Bullosa.走向细胞外囊泡治疗大疱性表皮松解症
Bioengineering (Basel). 2025 May 27;12(6):574. doi: 10.3390/bioengineering12060574.

本文引用的文献

8
Perivascular support of human hematopoietic stem/progenitor cells.人造血干/祖细胞的血管周支持。
Blood. 2013 Apr 11;121(15):2891-901. doi: 10.1182/blood-2012-08-451864. Epub 2013 Feb 14.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验